Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01178 | 34838723 | Clin Gastroenterol Hepatol | Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01179 | 34838715 | Mol Metab | A novel role of CRTC2 in promoting nonalcoholic fatty liver disease. | 2021 | Details |
| A01180 | 34838052 | J Nanobiotechnology | Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7. | 2021 | Details |
| A01181 | 34837012 | Sci Rep | Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model. | 2021 | Details |
| A01182 | 34836382 | Nutrients | The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities. | 2021 | Details |
| A01183 | 34836332 | Nutrients | Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01184 | 34836318 | Nutrients | Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults. | 2021 | Details |
| A01185 | 34836315 | Nutrients | Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols. | 2021 | Details |
| A01186 | 34836021 | Nutrients | Euphausia pacifica (North Pacific Krill): Review of Chemical Features and Potential Benefits of 8-HEPE against Metabolic Syndrome, Dyslipidemia, NAFLD, and Atherosclerosis. | 2021 | Details |
| A01187 | 34835981 | Nutrients | Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice. | 2021 | Details |
| A01188 | 34835949 | Nutrients | Effects of Lingonberry (Vaccinium vitis-idaea L.) Supplementation on Hepatic Gene Expression in High-Fat Diet Fed Mice. | 2021 | Details |
| A01189 | 34835937 | Nutrients | Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study. | 2021 | Details |
| A01190 | 34835476 | Microorganisms | Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. | 2021 | Details |
| A01191 | 34835410 | Microorganisms | Polyclonal Aptamers for Specific Fluorescence Labeling and Quantification of the Health Relevant Human Gut Bacterium Parabacteroides distasonis. | 2021 | Details |
| A01192 | 34833467 | Medicina (Kaunas) | Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients. | 2021 | Details |
| A01193 | 34831479 | Cells | Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01194 | 34831201 | Cells | Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. | 2021 | Details |
| A01195 | 34831031 | Cells | Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01196 | 34830997 | Cancers (Basel) | Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach. | 2021 | Details |
| A01197 | 34830641 | J Clin Med | Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease-A Single Center Experience. | 2021 | Details |
| A01198 | 34830360 | Int J Mol Sci | Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD. | 2021 | Details |
| A01199 | 34830313 | Int J Mol Sci | Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01200 | 34830072 | Int J Mol Sci | T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01201 | 34829968 | Biomedicines | The Role of Neuropeptide Y in Adipocyte-Macrophage Crosstalk during High Fat Diet-Induced Adipose Inflammation and Liver Steatosis. | 2021 | Details |
| A01202 | 34829926 | Biomedicines | Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. | 2021 | Details |
| A01203 | 34829889 | Biomedicines | Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies. | 2021 | Details |
| A01204 | 34829876 | Biomedicines | Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. | 2021 | Details |
| A01205 | 34829865 | Biomedicines | Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers. | 2021 | Details |
| A01206 | 34829779 | Biomedicines | Sex-Dependent Effects of Eicosapentaenoic Acid on Hepatic Steatosis in UCP1 Knockout Mice. | 2021 | Details |
| A01207 | 34829753 | Biomedicines | Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. | 2021 | Details |
| A01208 | 34829565 | Antioxidants (Basel) | Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity. | 2021 | Details |
| A01209 | 34829402 | Diagnostics (Basel) | Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets. | 2021 | Details |
| A01210 | 34829394 | Diagnostics (Basel) | A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV. | 2021 | Details |
| A01211 | 34828697 | Children (Basel) | Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity. | 2021 | Details |
| A01212 | 34828420 | Genes (Basel) | Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study. | 2021 | Details |
| A01213 | 34828259 | Genes (Basel) | Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition. | 2021 | Details |
| A01214 | 34827721 | Biomolecules | The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01215 | 34827579 | Biomolecules | Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms. | 2021 | Details |
| A01216 | 34826603 | Pharmacol Res | Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast. | 2021 | Details |
| A01217 | 34826302 | Am J Case Rep | A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH). | 2021 | Details |
| A01218 | 34825156 | JHEP Rep | Bile acids contribute to the development of non-alcoholic steatohepatitis in mice. | 2021 | Details |
| A01219 | 34825068 | Biochem Biophys Rep | Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. | 2021 | Details |
| A01220 | 34823548 | J Transl Med | CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype. | 2021 | Details |
| A01221 | 34823063 | Cell Mol Gastroenterol Hepatol | TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models. | 2021 | Details |
| A01224 | 34822647 | Vet Sci | Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation. | 2021 | Details |
| A01225 | 34822586 | Toxins (Basel) | Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis. | 2021 | Details |
| A01226 | 34822420 | Metabolites | Hepatic Response of Magnesium-Restricted Wild Type Mice. | 2021 | Details |
| A01227 | 34822395 | Metabolites | Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. | 2021 | Details |
| A01228 | 34822057 | Hepatol Int | Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure. | 2021 | Details |
| A01229 | 34821899 | Food Funct | Maternal sucralose exposure induces Paneth cell defects and exacerbates gut dysbiosis of progeny mice. | 2021 | Details |
| A01230 | 34821093 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism]. | 2021 | Details |
| A01231 | 34821035 | Liver Int | Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. | 2021 | Details |
| A01232 | 34819920 | Front Endocrinol (Lausanne) | Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01233 | 34819792 | Saudi Pharm J | Cold-pressed raspberry seeds oil ameliorates high-fat diet triggered non-alcoholic fatty liver disease. | 2021 | Details |
| A01234 | 34819740 | Clin Exp Gastroenterol | Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks. | 2021 | Details |
| A01235 | 34819013 | Endocr Metab Immune Disord Drug Targets | Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases. | 2022 | Details |
| A01236 | 34818372 | PLoS One | Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study. | 2021 | Details |
| A01237 | 34818080 | Metab Syndr Relat Disord | Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01238 | 34817929 | Liver Int | Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health. | 2021 | Details |
| A01239 | 34817071 | FEBS Lett | Comparative proteomic profiling reveals a pathogenic role for the O-GlcNAcylated AIMP2-PARP1 complex in aging-related hepatic steatosis in mice. | 2021 | Details |
| A01240 | 34816913 | Rev Assoc Med Bras (1992) | Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A01242 | 34816355 | Obes Surg | Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. | 2021 | Details |
| A01243 | 34816009 | JGH Open | Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis. | 2021 | Details |
| A01244 | 34815553 | Nat Rev Endocrinol | Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. | 2021 | Details |
| A01245 | 34815444 | Sci Rep | A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. | 2021 | Details |
| A01246 | 34815180 | Trends Mol Med | Linking liver metabolic and vascular disease via bile acid signaling. | 2021 | Details |
| A01247 | 34814851 | BMC Gastroenterol | Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. | 2021 | Details |
| A01248 | 34814419 | Zhonghua Liu Xing Bing Xue Za Zhi | [Analysis on influencing factors for nonalcoholic fatty liver disease in Jinchang cohort]. | 2021 | Details |
| A01249 | 34814397 | Zhonghua Gan Zang Bing Za Zhi | [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma]. | 2021 | Details |
| A01250 | 34814394 | Zhonghua Gan Zang Bing Za Zhi | [Serum exosomal miRNAs profiling and functional study in patients with non-alcoholic fatty liver disease]. | 2021 | Details |
| A01251 | 34814392 | Zhonghua Gan Zang Bing Za Zhi | [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus]. | 2021 | Details |
| A01252 | 34814152 | Ann Nutr Metab | Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study. | 2021 | Details |
| A01253 | 34813997 | Biomed Pharmacother | SP-1154, a novel synthetic TGF-β inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice. | 2021 | Details |
| A01255 | 34813621 | PLoS One | Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. | 2021 | Details |
| A01256 | 34813496 | Physiol Int | Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy. | 2021 | Details |
| A01257 | 34813379 | Metab Syndr Relat Disord | The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers. | 2021 | Details |
| A01258 | 34813249 | Arch Argent Pediatr | [Obesity-fatty liver: the role of the pediatrician]. | 2021 | Details |
| A01259 | 34811857 | Aging Cell | Cisd2 slows down liver aging and attenuates age-related metabolic dysfunction in male mice. | 2021 | Details |
| A01260 | 34811578 | Handb Exp Pharmacol | NAFLD and NASH: The Metabolically Diseased Liver. | 2021 | Details |
| A01261 | 34810377 | Saudi J Gastroenterol | Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies. | 2022 | Details |
| A01262 | 34810376 | Saudi J Gastroenterol | Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications. | 2022 | Details |
| A01263 | 34809436 | Annu Rev Med | Fatty Liver Disease: Diagnosis and Stratification. | 2021 | Details |
| A01264 | 34809412 | Endocrinol Metab (Seoul) | The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011). | 2021 | Details |
| A01265 | 34808701 | Phytother Res | Esculetin: A review of its pharmacology and pharmacokinetics. | 2021 | Details |
| A01266 | 34808618 | Dig Dis | The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency. | 2021 | Details |
| A01267 | 34808500 | Biochem Biophys Res Commun | Endoplasmic reticulum stress increases LECT2 expression via ATF4. | 2021 | Details |
| A01268 | 34808393 | Ann Hepatol | Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway. | 2021 | Details |
| A01269 | 34808388 | Bioorg Med Chem Lett | Design, synthesis and activity evaluation of prodrug form JBP485 and Vitamin E for alleviation of NASH. | 2021 | Details |
| A01270 | 34808224 | J Pediatr | Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths. | 2021 | Details |
| A01271 | 34806071 | Lancet Reg Health Eur | Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding. | 2021 | Details |
| A01272 | 34806068 | Lancet Reg Health Eur | Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study. | 2021 | Details |
| A01273 | 34805816 | JHEP Rep | Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review. | 2021 | Details |
| A01274 | 34805582 | Transl Gastroenterol Hepatol | Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis. | 2021 | Details |
| A01275 | 34805412 | J Diabetes Res | Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus. | 2021 | Details |
| A01277 | 34805029 | Can J Gastroenterol Hepatol | GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. | 2021 | Details |
| A01278 | 34803928 | Front Endocrinol (Lausanne) | Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD. | 2021 | Details |
| A01279 | 34803916 | Front Endocrinol (Lausanne) | Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases. | 2021 | Details |
| A01280 | 34803681 | Front Pharmacol | The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A01281 | 34803499 | Int J Biol Sci | CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD+/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes. | 2021 | Details |
| A01282 | 34803493 | Int J Biol Sci | Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer. | 2021 | Details |